Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 11Phase NA 3Phase 4 3Phase 1/2 3Phase 3 2

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1NET 1Endocrine 1Breast 1

Conditions

Carcinoma, Renal Cell 5Neuroendocrine Tumors 3Neoplasms 3Tuberous Sclerosis 2Kidney Neoplasms 2Breast Neoplasms 2Angiomyolipoma 2Waldenstrom Macroglobulinemia 1Skin Neoplasms 1Skin Diseases 1Pancreatic Neuroendocrine Tumors 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma 1Lymphangioleiomyomatosis 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Carcinoma, Large Cell 1Carcinoma, Hepatocellular 1Carcinoid Tumor 1Breast Diseases 1

Interventions

Dexamethasone 8Oxycodone 6Epoetin Alfa 5Propofol 4Palonosetron 4Meropenem 4Zoledronic Acid 3Vancomycin 3Sevoflurane 3Ondansetron 3Naloxone 3Everolimus 3Ciprofloxacin 3Cholecalciferol 3Ceftazidime 3Cefepime 3Calcium Dobesilate 3Bevacizumab 3Aspirin 3Aprepitant 3peginterferon alfa-2a 2edoxaban 2apixaban 2apatinib 2Vitamin B 12 2Vincristine 2Tobacco Use Cessation Devices 2Teicoplanin 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms × Everolimus × Clear all
NCT01789281 2021-06-11

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

Novartis

Phase 4 Completed
34 enrolled 8 charts
EndocrineNET

Carcinoid Tumor, Neoplasms, Neuroendocrine Tumors

NCT01743560 2019-07-18

4EVERUK

Novartis

Phase 4 Completed
52 enrolled 16 charts
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

NCT00903188 2009-05-18

CISTCERT

University Hospital, Antwerp

Phase 4 Unknown
152 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡